Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junhai Ma

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Oxidative Medicine and Cellular Longevity|December 15, 2016
Calcium Oxalate Induces Renal Injury through Calcium-Sensing ReceptorXiaoran Li, Junhai Ma, Wei Shi, et al.
Scientific Reports|April 3, 2025
Energy efficiency evaluation of construction projects using data envelopment analysis and Tobit regressionMuzaffar Iqbal, Junhai Ma, Zulqarnain Mushtaq, et al.
Journal of Oncology|July 26, 2021
Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA PathwayDongyang Gao, Qian Niu, Yuwen Gong, et al.
Free Radical Biology & Medicine|September 19, 2023
CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathwayDongyang Gao, Runchang Wang, Yuwen Gong, et al.
Frontiers in Immunology|January 22, 2026
Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective studyShuaipeng He, Cheng Wang, Xuan Li, et al.
Cellular Signalling|June 2, 2026
ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancerYao Luo, Junhai Ma, Cheng Wang, et al.
World Journal of Urology|June 13, 2026
Development and multicohort validation of an interpretable postoperative model for intravesical recurrence after radical nephroureterectomy in upper tract urothelial carcinomaCheng Wang, Shuaipeng He, Biao Zhang, et al.
Frontiers in Immunology|July 1, 2026
Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative studyCheng Wang, Shuaipeng He, Dan Li, et al.
BMC Urology|February 3, 2024
Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trialJunyao Liu, Bin Zhang, Peng Qi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oxidative Medicine and Cellular Longevity|December 15, 2016
Calcium Oxalate Induces Renal Injury through Calcium-Sensing ReceptorXiaoran Li, Junhai Ma, Wei Shi, et al.
Scientific Reports|April 3, 2025
Energy efficiency evaluation of construction projects using data envelopment analysis and Tobit regressionMuzaffar Iqbal, Junhai Ma, Zulqarnain Mushtaq, et al.
Journal of Oncology|July 26, 2021
Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA PathwayDongyang Gao, Qian Niu, Yuwen Gong, et al.
Free Radical Biology & Medicine|September 19, 2023
CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathwayDongyang Gao, Runchang Wang, Yuwen Gong, et al.
Frontiers in Immunology|January 22, 2026
Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective studyShuaipeng He, Cheng Wang, Xuan Li, et al.
Cellular Signalling|June 2, 2026
ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancerYao Luo, Junhai Ma, Cheng Wang, et al.
World Journal of Urology|June 13, 2026
Development and multicohort validation of an interpretable postoperative model for intravesical recurrence after radical nephroureterectomy in upper tract urothelial carcinomaCheng Wang, Shuaipeng He, Biao Zhang, et al.
Frontiers in Immunology|July 1, 2026
Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative studyCheng Wang, Shuaipeng He, Dan Li, et al.
BMC Urology|February 3, 2024
Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trialJunyao Liu, Bin Zhang, Peng Qi, et al.
Pageof 2